These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12518271

  • 1. Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
    Berecz R, LLerena A, de la Rubia A, Gómez J, Kellermann M, Dorado P, Degrell I.
    Pharmacopsychiatry; 2002 Nov; 35(6):231-4. PubMed ID: 12518271
    [Abstract] [Full Text] [Related]

  • 2. Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia.
    Yasui-Furukori N, Mihara K, Kondo T, Kubota T, Iga T, Takarada Y, De Vries R, Kaneko S, Tateishi T.
    J Clin Pharmacol; 2003 Feb; 43(2):122-7. PubMed ID: 12616663
    [Abstract] [Full Text] [Related]

  • 3. Risperidone plasma levels, clinical response and side-effects.
    Riedel M, Schwarz MJ, Strassnig M, Spellmann I, Müller-Arends A, Weber K, Zach J, Müller N, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia.
    Mihara K, Kondo T, Yasui-Furukori N, Suzuki A, Ishida M, Ono S, Kubota T, Iga T, Takarada Y, de Vries R, Kaneko S.
    Ther Drug Monit; 2003 Jun; 25(3):287-93. PubMed ID: 12766554
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.
    Sherwin CM, Saldaña SN, Bies RR, Aman MG, Vinks AA.
    Ther Drug Monit; 2012 Oct; 34(5):535-44. PubMed ID: 22929407
    [Abstract] [Full Text] [Related]

  • 10. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Yagihashi T, Mizuno M, Chino B, Sato Y, Sakuma K, Takebayashi T, Takao T, Kosaki K.
    Hum Psychopharmacol; 2009 Jun; 24(4):301-8. PubMed ID: 19387994
    [Abstract] [Full Text] [Related]

  • 11. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
    Leon Jd, Susce MT, Pan RM, Wedlund PJ, Orrego ML, Diaz FJ.
    Pharmacopsychiatry; 2007 May; 40(3):93-102. PubMed ID: 17541883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
    Kang RH, Jung SM, Kim KA, Lee DK, Cho HK, Jung BJ, Kim YK, Kim SH, Han C, Lee MS, Park JY.
    J Clin Psychopharmacol; 2009 Jun; 29(3):272-7. PubMed ID: 19440082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10.
    Yoo HD, Lee SN, Kang HA, Cho HY, Lee IK, Lee YB.
    Br J Pharmacol; 2011 Sep; 164(2b):433-43. PubMed ID: 21449914
    [Abstract] [Full Text] [Related]

  • 20. Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.
    Suzuki Y, Fukui N, Tsuneyama N, Watanabe J, Ono S, Sugai T, Saito M, Inoue Y, Someya T.
    Hum Psychopharmacol; 2012 Jan; 27(1):43-6. PubMed ID: 22745940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.